Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Methods and protocols to study T cell signaling abnormalities in human systemic lupus erythematosus.

Moulton VR, Lo MS, Tsokos GC.

Methods Mol Biol. 2012;900:25-60. doi: 10.1007/978-1-60761-720-4_3.

PMID:
22933064
2.

T-cell signaling abnormalities in human systemic lupus erythematosus.

Nambiar MP, Krishnan S, Tsokos GC.

Methods Mol Med. 2004;102:31-47.

PMID:
15286379
3.

TCR zeta-chain abnormalities in human systemic lupus erythematosus.

Nambiar MP, Krishnan S, Warke VG, Tsokos GC.

Methods Mol Med. 2004;102:49-72.

PMID:
15286380
4.
5.

Abnormal expression of various molecular forms and distribution of T cell receptor zeta chain in patients with systemic lupus erythematosus.

Nambiar MP, Enyedy EJ, Fisher CU, Krishnan S, Warke VG, Gilliland WR, Oglesby RJ, Tsokos GC.

Arthritis Rheum. 2002 Jan;46(1):163-74.

6.

Dissecting the molecular mechanisms of TCR zeta chain downregulation and T cell signaling abnormalities in human systemic lupus erythematosus.

Nambiar MP, Juang YT, Krishnan S, Tsokos GC.

Int Rev Immunol. 2004 May-Aug;23(3-4):245-63. Review.

PMID:
15204087
7.

Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus.

Enyedy EJ, Nambiar MP, Liossis SN, Dennis G, Kammer GM, Tsokos GC.

Arthritis Rheum. 2001 May;44(5):1114-21.

8.

Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus.

Krishnan S, Nambiar MP, Warke VG, Fisher CU, Mitchell J, Delaney N, Tsokos GC.

J Immunol. 2004 Jun 15;172(12):7821-31.

9.

Decreased SAP Expression in T Cells from Patients with Systemic Lupus Erythematosus Contributes to Early Signaling Abnormalities and Reduced IL-2 Production.

Karampetsou MP, Comte D, Kis-Toth K, Terhorst C, Kyttaris VC, Tsokos GC.

J Immunol. 2016 Jun 15;196(12):4915-24. doi: 10.4049/jimmunol.1501523. Epub 2016 May 11.

10.

Increased caspase-3 expression and activity contribute to reduced CD3zeta expression in systemic lupus erythematosus T cells.

Krishnan S, Kiang JG, Fisher CU, Nambiar MP, Nguyen HT, Kyttaris VC, Chowdhury B, Rus V, Tsokos GC.

J Immunol. 2005 Sep 1;175(5):3417-23.

11.

Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells.

Krishnan S, Juang YT, Chowdhury B, Magilavy A, Fisher CU, Nguyen H, Nambiar MP, Kyttaris V, Weinstein A, Bahjat R, Pine P, Rus V, Tsokos GC.

J Immunol. 2008 Dec 1;181(11):8145-52.

12.

Abnormalities of T cell signaling in systemic lupus erythematosus.

Moulton VR, Tsokos GC.

Arthritis Res Ther. 2011 Mar 17;13(2):207. doi: 10.1186/ar3251. Review.

13.

Linker for activation of T cells is displaced from lipid rafts and decreases in lupus T cells after activation via the TCR/CD3 pathway.

Abdoel N, Brun S, Bracho C, Rodríguez MA, Blasini AM.

Clin Immunol. 2012 Mar;142(3):243-51. doi: 10.1016/j.clim.2011.12.010. Epub 2011 Dec 30.

PMID:
22285373
14.

Attempt to correct abnormal signal transduction in T lymphocytes from systemic lupus erythematosus patients.

Fujii Y, Fujii K, Tanaka Y.

Autoimmun Rev. 2006 Feb;5(2):143-4. Epub 2005 Sep 19. Review.

PMID:
16431347
15.

Abnormal pattern of tyrosine phosphorylation in unstimulated peripheral blood T lymphocytes from patients with systemic lupus erythematosus.

Blasini AM, Alonzo E, Chacón R, Riera R, Stekman IL, Rodriguez MA.

Lupus. 1998;7(8):515-23.

PMID:
9863892
16.

Altered T and B lymphocyte signaling pathways in lupus.

Peng SL.

Autoimmun Rev. 2009 Jan;8(3):179-83. doi: 10.1016/j.autrev.2008.07.040. Epub 2008 Aug 20. Review.

PMID:
18721908
17.

T cell abnormalities in systemic lupus erythematosus.

Takeuchi T, Tsuzaka K, Abe T, Yoshimoto K, Shiraishi K, Kameda H, Amano K.

Autoimmunity. 2005 Aug;38(5):339-46. Review.

PMID:
16227148
18.
19.

Abnormal early TCR/CD3-mediated signaling events of a snRNP-autoreactive lupus T cell clone.

Liossis SN, Hoffman RW, Tsokos GC.

Clin Immunol Immunopathol. 1998 Sep;88(3):305-10.

PMID:
9743618

Supplemental Content

Support Center